N-氰基-N'-甲基-胍 | 1609-07-0

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-氰基-N'-甲基-胍
• 英文名称: 1-cyano-3-methyl-guanidine
• 英文别名: N-cyano-N’-methylguanidine；1-cyano-3-methylguanidine；1-methyl-3-cyanoguanidine；N-cyano-N'-methyl-guanidine；N-Cyan-N'-methyl-guanidin；N-cyano-N'-methylguanidine；1-cyano-2-methylguanidine
• CAS: 1609-07-0
• 化学式: C₃H₆N₄
• mdl: MFCD01871337
• 分子量: 98.1074
• InChiKey: SIQWQBQGWREFSE-UHFFFAOYSA-N

物化性质

• 熔点：
  91-92 °C
• 沸点：
  119.2±23.0 °C(Predicted)
• 密度：
  1.18±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  7
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  74.2
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2926909090

反应信息

• 作为反应物：
  描述：

  N-氰基-N'-甲基-胍 以52%的产率得到
  参考文献：
  名称：

  IIO, KOKORO;ICHIKAWA, EIICHI, BULL. CHEM. SOC. JAP., 1985, 58, N 9, 2735-2736

  摘要：

  DOI：
• 作为产物：
  描述：

  N-氰基-N',S-二甲基异硫脲 在 乙醇 、 氨 作用下， 生成 N-氰基-N'-甲基-胍
  参考文献：
  名称：

  May, Journal of Organic Chemistry, 1947, vol. 12, p. 440 Anm.6

  摘要：

  DOI：

文献信息

• On the anomalous sorption behaviour of chlorhexidine with poly(2-hydroxyethyl methacrylate)
  作者：B S Plaut、B J Meakin、D J G Davies

  DOI：10.1111/j.2042-7158.1980.tb12989.x

  日期：2011.4.12

  General observations of solute: plastic interactions would suggest that the sorption of the cationic preservative, chlorhexidine, with poly (2-hydroxyethyl methacrylate) (PHEMA) is not only unexpected but also atypical in its properties. The polymer and preservative were investigated independently and the sorption of PHEMA with simple solutes, namely benzoic acid, benzocaine and aniline found to exhibit conventional properties. The single exception was the uptake of small amounts of benzocaine and aniline cations at acidic pH's. In order to elucidate the sorption characteristics of chlorhexidine a series of N1-(p-chlorophenyl)-N5-alkylbiguanide acetates were synthesized. The anomalous sorption behaviour observed between PHEMA and the bis biguanide, chlorhexidine, was also found to be characteristic of these monofunctional biguanide derivatives. The extent of the interactions increased with increasing alkyl chain length (R = methyl to n-octyl), this being interpreted in terms of an interaction binding mechanism via the biguanide functional group stabilized by van der Waal's forces between the alkyl chain and the polymer backbone. Atypical sorption behaviour was observed for simple organic cations, biguanide and N1-phenylbiguanide acetate with PHEMA, a possible inference being that this is a general characteristic of all cationic sorption with PHEMA.

  关于溶质：塑料相互作用的总体观察表明，阳离子防腐剂氯己定的吸附与聚（2-羟基乙基甲基丙烯酸酯）（PHEMA）的吸附不仅是出乎意料的，而且在其性质上也是非典型的。研究了聚合物和防腐剂，发现PHEMA与简单溶质（即苯甲酸、苯佐卡因和苯胺）的吸附表现出常规性质。唯一的例外是在酸性pH下，苯佐卡因和苯胺阳离子的小量吸收。为了阐明氯己定的吸附特性，合成了一系列N1-（对氯苯基）-N5-烷基双胍醋酸盐。在PHEMA与双胍，氯己定之间的异常吸附行为也发现是这些单功能双胍衍生物的特征。随着烷基链长（R =甲基至正辛基）的增加，相互作用的程度增加，这被解释为通过双胍功能团介导的相互作用结合机制，该机制通过烷基链与聚合物主链之间的范德华力得到稳定。简单有机阳离子、双胍和N1-苯基双胍醋酸盐与PHEMA的吸附表现出非典型的吸附行为，可能的推断是这是所有阳离子与PHEMA吸附的一般特征。

• 1,5-Disubstituted biguanides
  申请人：William H. Rorer, Inc.

  公开号：US03996232A1

  公开（公告）日：1976-12-07

  Novel 1-aryl and aralkyl 5-substituted biguanide compounds have been prepared. The compounds of this invention possess useful antiulcerogenic properties.

  1-芳基和芳烷基5-取代的双胍化合物已经制备出来。本发明的化合物具有有用的抗溃疡生成特性。
• Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome
  作者：Yu Zhou、Jing Ma、Xingyu Lin、Xi-Ping Huang、Kaichun Wu、Niu Huang

  DOI：10.1021/acs.jmedchem.5b01631

  日期：2016.1.28

  Here we employed structure-based ligand discovery techniques to explore a recently determined crystal structure of the 5-hydroxytryptamine 2B (5-HT2B) receptor. Ten compounds containing a novel chemical scaffold were identified; among them, seven molecules were active in cellular function assays with the most potent one exhibiting an IC50 value of 27.3 nM. We then systematically probed the binding

  在这里，我们采用了基于结构的配体发现技术，以探索最近确定的5-羟色胺2B（5-HT 2B）受体的晶体结构。鉴定出了十种含有新型化学支架的化合物。其中，有七个分子在细胞功能测定中具有活性，其中最有力的一个，其IC 50值为27.3 nM。然后，我们通过设计，合成和测试一系列结构修饰，系统地研究了该支架的结合特性。结构-活性关系研究强烈支持我们预测的结合模型。跨越11种5-HT受体的结合谱表明，这些化合物对5-HT 2B受体具有高度选择性。口服化合物15（30 mg / kg）可明显减轻肠易激综合征（IBS）大鼠内脏超敏性。我们希望这种新型支架将为开发用于治疗IBS的5-HT 2B拮抗剂奠定基础。
• Synthesis of Guanidino-1,3,5-triazines Using DMF
  作者：Kokoro Iio、Eiichi Ichikawa

  DOI：10.1246/bcsj.58.2735

  日期：1985.9

  2,4,6-Triguanidino-1,3,5-triazine and 2,4,6-tris(3-methylguanidino)-1,3,5-triazine were synthesized in 42 and 52% yields, respectively, by the cyclotrimerization of cyanoguanidine and 1-methyl-3-cyanoguanidine using DMF as a solvent in the presence of hydrogen chloride. 1-Phenyl-3-cyanoguanidine, 1,2-dimethyl-3-cyanoguanidine, and 2-imidazolidinylidenecyanamide, however, were cyclodimerized to the corresponding guanidino-1,3,5-triazines in a similar manner.

  2,4,6-三氟胍基-1,3,5-三嗪和2,4,6-三(3-甲基胍基)-1,3,5-三嗪分别通过在盐酸存在下使用DMF作为溶剂对氰胍和1-甲基-3-氰胍进行环 trimerization合成，产率为42%和52%。然而，1-苯基-3-氰胍、1,2-二甲基-3-氰胍和2-咪唑啉基氰胺则以类似方式环二聚为相应的胍基-1,3,5-三嗪。
• 2-guanidino-4-aryl-quinazoline
  申请人：——

  公开号：US20040039001A1

  公开（公告）日：2004-02-26

  The invention relates to compounds of the formula I, in which Y is (II) or (III) and Ar, R 1 , R 2 , R 5 , R 6 , R 7 and R 8 are as defined above, and their salts and solvates, and to their use as NHE-3 inhibitors. 1

  这项发明涉及到式I的化合物，其中Y是(II)或(III)，Ar、R1、R2、R5、R6、R7和R8如上所定义，并且它们的盐和溶剂合物，以及它们作为NHE-3抑制剂的用途。